Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation

Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation

Background Cytomegalovirus (CMV) reactivation after unmanipulated haploidentical stem cell transplantation (SCT) frequently occurs, causing life-threatening morbidities and transplantation failure. Pre-emptive therapy upon the detection of CMV viremia using antiviral agents is currently the standard...

Full description

Bibliographic Details
Main Authors: Yu Wang, Lu Wang, Chao Ma, Peng Chen, Ning Lu, Jishan Du, Jiaojun Sun, Xu Qilong, Liping Dou, Dai-Hong Liu
Format: Article
Language:English
Published: BMJ Publishing Group 2024-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/1/e007735.full

Internet

https://jitc.bmj.com/content/12/1/e007735.full

Similar Items